Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation

Objective To describe the first live birth after transplantation of ovarian tissue following overnight transportation of the tissue before freezing. Design Technical note. Setting University department of obstetrics and gynecology. Patient(s) A 25-year-old cancer survivor with previous Hodgkin disea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 2012-02, Vol.97 (2), p.387-390
Hauptverfasser: Dittrich, Ralf, Ph.D, Lotz, Laura, Keck, Gudrun, Ph.D, Hoffmann, Inge, Mueller, Andreas, M.D, Beckmann, Matthias W., M.D, van der Ven, Hans, M.D, Montag, Markus, Ph.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 390
container_issue 2
container_start_page 387
container_title Fertility and sterility
container_volume 97
creator Dittrich, Ralf, Ph.D
Lotz, Laura
Keck, Gudrun, Ph.D
Hoffmann, Inge
Mueller, Andreas, M.D
Beckmann, Matthias W., M.D
van der Ven, Hans, M.D
Montag, Markus, Ph.D
description Objective To describe the first live birth after transplantation of ovarian tissue following overnight transportation of the tissue before freezing. Design Technical note. Setting University department of obstetrics and gynecology. Patient(s) A 25-year-old cancer survivor with previous Hodgkin disease and relapse. Intervention(s) The ovarian tissue was kept cool for >20 hours in a special transport medium and a special cooling device before it was cryopreserved. After premature ovarian failure due to preconditioning chemotherapy for bone marrow transplantation, the cryopreserved ovarian tissue was transplanted orthotopically. Main Outcome Measure(s) Resumption of ovarian function after transplantation, recovery of fertility, and pregnancy. Result(s) Ovarian function returned in the patient 3 months after transplantation, as shown by follicle development and estrogen production. During the fifth menstrual cycle, mild stimulation with FSH was initiated in accordance with a low-dose protocol. When ultrasonography revealed a follicle 18–20 mm in size in the ovarian graft, hCG was added and the patient had sexual intercourse at the optimal time point. On day 14 of the luteal phase, hCG concentration and vaginal echography confirmed a viable intrauterine pregnancy, which resulted in a healthy live birth. Conclusion(s) Overnight transportation of ovarian tissue appears to be possible in combination with appropriate transportation logistics. However, further investigations are needed before this procedure can be offered as a chance for women to preserve fertility independently of direct access to a tissue-processing bank.
doi_str_mv 10.1016/j.fertnstert.2011.11.047
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_919226781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028211028238</els_id><sourcerecordid>919226781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c598t-5c1cc90c3e95f5fe40885398858feae102c5afab51e525d0ebdea2543d96bc283</originalsourceid><addsrcrecordid>eNqNkk1vEzEQhi0EomnhL8BeEKcNtjfejwsSraAgReJQera83nHqsLHD2BuUf88sCVTihGSNJeuZd8bvDGOF4EvBRf1uu3SAOaRMcSm5EEs6fNU8YQuhVF2qWlVP2YJzoUouW3nBLlPacs5r0cjn7EJK0TSVEAsW1v4ARe8xPxTGkV4RDwa9CUX2KU1QmCnHjCak_WhCNtnHULg4jvGnDxuCAYPfPOTixEQ8Iz24iFBYPMY9QgI8_H5_wZ45MyZ4eb6v2P2nj99uPpfrr7dfbj6sS6u6NpfKCms7bivolFMOVrxtVdVRaB0YEFxaZZzplQAl1cChH8BItaqGru6tbKsr9vaku8f4Y4KU9c4nCyP9AeKUdCc6KeumFUS2J9JiTAnB6T36ncGjFlzPZuutfjRbz2ZrOmQ2pb46F5n6HQx_E_-4S8CbM2CSNaMji6xPj5yqieI1ca9PnDNRmw0Sc39HlRQNkKbXzUrXJwLItIMH1Ml6CBYGj2CzHqL_n37f_yNiRx88dfYdjpC2ccJAQ9FCJ6m5vpvXZ94e6pFi1Va_AC9nxRk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>919226781</pqid></control><display><type>article</type><title>Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Dittrich, Ralf, Ph.D ; Lotz, Laura ; Keck, Gudrun, Ph.D ; Hoffmann, Inge ; Mueller, Andreas, M.D ; Beckmann, Matthias W., M.D ; van der Ven, Hans, M.D ; Montag, Markus, Ph.D</creator><creatorcontrib>Dittrich, Ralf, Ph.D ; Lotz, Laura ; Keck, Gudrun, Ph.D ; Hoffmann, Inge ; Mueller, Andreas, M.D ; Beckmann, Matthias W., M.D ; van der Ven, Hans, M.D ; Montag, Markus, Ph.D</creatorcontrib><description>Objective To describe the first live birth after transplantation of ovarian tissue following overnight transportation of the tissue before freezing. Design Technical note. Setting University department of obstetrics and gynecology. Patient(s) A 25-year-old cancer survivor with previous Hodgkin disease and relapse. Intervention(s) The ovarian tissue was kept cool for &gt;20 hours in a special transport medium and a special cooling device before it was cryopreserved. After premature ovarian failure due to preconditioning chemotherapy for bone marrow transplantation, the cryopreserved ovarian tissue was transplanted orthotopically. Main Outcome Measure(s) Resumption of ovarian function after transplantation, recovery of fertility, and pregnancy. Result(s) Ovarian function returned in the patient 3 months after transplantation, as shown by follicle development and estrogen production. During the fifth menstrual cycle, mild stimulation with FSH was initiated in accordance with a low-dose protocol. When ultrasonography revealed a follicle 18–20 mm in size in the ovarian graft, hCG was added and the patient had sexual intercourse at the optimal time point. On day 14 of the luteal phase, hCG concentration and vaginal echography confirmed a viable intrauterine pregnancy, which resulted in a healthy live birth. Conclusion(s) Overnight transportation of ovarian tissue appears to be possible in combination with appropriate transportation logistics. However, further investigations are needed before this procedure can be offered as a chance for women to preserve fertility independently of direct access to a tissue-processing bank.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/j.fertnstert.2011.11.047</identifier><identifier>PMID: 22177311</identifier><identifier>CODEN: FESTAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; animal ovaries ; Antineoplastic Agents - adverse effects ; autografting ; Biological and medical sciences ; bone marrow transplant ; Bone Marrow Transplantation ; chemotherapy ; cooling ; Cryopreservation ; Equipment Design ; Female ; Fertility Agents, Female - administration &amp; dosage ; Fertility preservation ; Fertility Preservation - methods ; follicle-stimulating hormone ; freezing ; Gynecology. Andrology. Obstetrics ; Hodgkin disease ; Hodgkin Disease - drug therapy ; Hodgkin Disease - surgery ; Hodgkin Disease - therapy ; human chorionic gonadotropin ; Humans ; Internal Medicine ; Live Birth ; Medical sciences ; menstrual cycle ; Obstetrics and Gynecology ; Organ Preservation ; Organ Preservation Solutions - therapeutic use ; orthotopic ; ovarian tissue cryopreservation ; ovarian tissue transplantation ; Ovary - transplantation ; patients ; Pregnancy ; Primary Ovarian Insufficiency - chemically induced ; Primary Ovarian Insufficiency - surgery ; Recurrence ; relapse ; Time Factors ; Transplantation Conditioning - adverse effects ; Transplantation, Autologous ; transportation ; Transportation - instrumentation ; Treatment Outcome ; ultrasonography ; women</subject><ispartof>Fertility and sterility, 2012-02, Vol.97 (2), p.387-390</ispartof><rights>American Society for Reproductive Medicine</rights><rights>2012 American Society for Reproductive Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c598t-5c1cc90c3e95f5fe40885398858feae102c5afab51e525d0ebdea2543d96bc283</citedby><cites>FETCH-LOGICAL-c598t-5c1cc90c3e95f5fe40885398858feae102c5afab51e525d0ebdea2543d96bc283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028211028238$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25631106$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22177311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dittrich, Ralf, Ph.D</creatorcontrib><creatorcontrib>Lotz, Laura</creatorcontrib><creatorcontrib>Keck, Gudrun, Ph.D</creatorcontrib><creatorcontrib>Hoffmann, Inge</creatorcontrib><creatorcontrib>Mueller, Andreas, M.D</creatorcontrib><creatorcontrib>Beckmann, Matthias W., M.D</creatorcontrib><creatorcontrib>van der Ven, Hans, M.D</creatorcontrib><creatorcontrib>Montag, Markus, Ph.D</creatorcontrib><title>Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>Objective To describe the first live birth after transplantation of ovarian tissue following overnight transportation of the tissue before freezing. Design Technical note. Setting University department of obstetrics and gynecology. Patient(s) A 25-year-old cancer survivor with previous Hodgkin disease and relapse. Intervention(s) The ovarian tissue was kept cool for &gt;20 hours in a special transport medium and a special cooling device before it was cryopreserved. After premature ovarian failure due to preconditioning chemotherapy for bone marrow transplantation, the cryopreserved ovarian tissue was transplanted orthotopically. Main Outcome Measure(s) Resumption of ovarian function after transplantation, recovery of fertility, and pregnancy. Result(s) Ovarian function returned in the patient 3 months after transplantation, as shown by follicle development and estrogen production. During the fifth menstrual cycle, mild stimulation with FSH was initiated in accordance with a low-dose protocol. When ultrasonography revealed a follicle 18–20 mm in size in the ovarian graft, hCG was added and the patient had sexual intercourse at the optimal time point. On day 14 of the luteal phase, hCG concentration and vaginal echography confirmed a viable intrauterine pregnancy, which resulted in a healthy live birth. Conclusion(s) Overnight transportation of ovarian tissue appears to be possible in combination with appropriate transportation logistics. However, further investigations are needed before this procedure can be offered as a chance for women to preserve fertility independently of direct access to a tissue-processing bank.</description><subject>Adult</subject><subject>animal ovaries</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>autografting</subject><subject>Biological and medical sciences</subject><subject>bone marrow transplant</subject><subject>Bone Marrow Transplantation</subject><subject>chemotherapy</subject><subject>cooling</subject><subject>Cryopreservation</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Fertility Agents, Female - administration &amp; dosage</subject><subject>Fertility preservation</subject><subject>Fertility Preservation - methods</subject><subject>follicle-stimulating hormone</subject><subject>freezing</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hodgkin disease</subject><subject>Hodgkin Disease - drug therapy</subject><subject>Hodgkin Disease - surgery</subject><subject>Hodgkin Disease - therapy</subject><subject>human chorionic gonadotropin</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Live Birth</subject><subject>Medical sciences</subject><subject>menstrual cycle</subject><subject>Obstetrics and Gynecology</subject><subject>Organ Preservation</subject><subject>Organ Preservation Solutions - therapeutic use</subject><subject>orthotopic</subject><subject>ovarian tissue cryopreservation</subject><subject>ovarian tissue transplantation</subject><subject>Ovary - transplantation</subject><subject>patients</subject><subject>Pregnancy</subject><subject>Primary Ovarian Insufficiency - chemically induced</subject><subject>Primary Ovarian Insufficiency - surgery</subject><subject>Recurrence</subject><subject>relapse</subject><subject>Time Factors</subject><subject>Transplantation Conditioning - adverse effects</subject><subject>Transplantation, Autologous</subject><subject>transportation</subject><subject>Transportation - instrumentation</subject><subject>Treatment Outcome</subject><subject>ultrasonography</subject><subject>women</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1vEzEQhi0EomnhL8BeEKcNtjfejwsSraAgReJQera83nHqsLHD2BuUf88sCVTihGSNJeuZd8bvDGOF4EvBRf1uu3SAOaRMcSm5EEs6fNU8YQuhVF2qWlVP2YJzoUouW3nBLlPacs5r0cjn7EJK0TSVEAsW1v4ARe8xPxTGkV4RDwa9CUX2KU1QmCnHjCak_WhCNtnHULg4jvGnDxuCAYPfPOTixEQ8Iz24iFBYPMY9QgI8_H5_wZ45MyZ4eb6v2P2nj99uPpfrr7dfbj6sS6u6NpfKCms7bivolFMOVrxtVdVRaB0YEFxaZZzplQAl1cChH8BItaqGru6tbKsr9vaku8f4Y4KU9c4nCyP9AeKUdCc6KeumFUS2J9JiTAnB6T36ncGjFlzPZuutfjRbz2ZrOmQ2pb46F5n6HQx_E_-4S8CbM2CSNaMji6xPj5yqieI1ca9PnDNRmw0Sc39HlRQNkKbXzUrXJwLItIMH1Ml6CBYGj2CzHqL_n37f_yNiRx88dfYdjpC2ccJAQ9FCJ6m5vpvXZ94e6pFi1Va_AC9nxRk</recordid><startdate>20120201</startdate><enddate>20120201</enddate><creator>Dittrich, Ralf, Ph.D</creator><creator>Lotz, Laura</creator><creator>Keck, Gudrun, Ph.D</creator><creator>Hoffmann, Inge</creator><creator>Mueller, Andreas, M.D</creator><creator>Beckmann, Matthias W., M.D</creator><creator>van der Ven, Hans, M.D</creator><creator>Montag, Markus, Ph.D</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120201</creationdate><title>Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation</title><author>Dittrich, Ralf, Ph.D ; Lotz, Laura ; Keck, Gudrun, Ph.D ; Hoffmann, Inge ; Mueller, Andreas, M.D ; Beckmann, Matthias W., M.D ; van der Ven, Hans, M.D ; Montag, Markus, Ph.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c598t-5c1cc90c3e95f5fe40885398858feae102c5afab51e525d0ebdea2543d96bc283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>animal ovaries</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>autografting</topic><topic>Biological and medical sciences</topic><topic>bone marrow transplant</topic><topic>Bone Marrow Transplantation</topic><topic>chemotherapy</topic><topic>cooling</topic><topic>Cryopreservation</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Fertility Agents, Female - administration &amp; dosage</topic><topic>Fertility preservation</topic><topic>Fertility Preservation - methods</topic><topic>follicle-stimulating hormone</topic><topic>freezing</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hodgkin disease</topic><topic>Hodgkin Disease - drug therapy</topic><topic>Hodgkin Disease - surgery</topic><topic>Hodgkin Disease - therapy</topic><topic>human chorionic gonadotropin</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Live Birth</topic><topic>Medical sciences</topic><topic>menstrual cycle</topic><topic>Obstetrics and Gynecology</topic><topic>Organ Preservation</topic><topic>Organ Preservation Solutions - therapeutic use</topic><topic>orthotopic</topic><topic>ovarian tissue cryopreservation</topic><topic>ovarian tissue transplantation</topic><topic>Ovary - transplantation</topic><topic>patients</topic><topic>Pregnancy</topic><topic>Primary Ovarian Insufficiency - chemically induced</topic><topic>Primary Ovarian Insufficiency - surgery</topic><topic>Recurrence</topic><topic>relapse</topic><topic>Time Factors</topic><topic>Transplantation Conditioning - adverse effects</topic><topic>Transplantation, Autologous</topic><topic>transportation</topic><topic>Transportation - instrumentation</topic><topic>Treatment Outcome</topic><topic>ultrasonography</topic><topic>women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dittrich, Ralf, Ph.D</creatorcontrib><creatorcontrib>Lotz, Laura</creatorcontrib><creatorcontrib>Keck, Gudrun, Ph.D</creatorcontrib><creatorcontrib>Hoffmann, Inge</creatorcontrib><creatorcontrib>Mueller, Andreas, M.D</creatorcontrib><creatorcontrib>Beckmann, Matthias W., M.D</creatorcontrib><creatorcontrib>van der Ven, Hans, M.D</creatorcontrib><creatorcontrib>Montag, Markus, Ph.D</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dittrich, Ralf, Ph.D</au><au>Lotz, Laura</au><au>Keck, Gudrun, Ph.D</au><au>Hoffmann, Inge</au><au>Mueller, Andreas, M.D</au><au>Beckmann, Matthias W., M.D</au><au>van der Ven, Hans, M.D</au><au>Montag, Markus, Ph.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>2012-02-01</date><risdate>2012</risdate><volume>97</volume><issue>2</issue><spage>387</spage><epage>390</epage><pages>387-390</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><coden>FESTAS</coden><abstract>Objective To describe the first live birth after transplantation of ovarian tissue following overnight transportation of the tissue before freezing. Design Technical note. Setting University department of obstetrics and gynecology. Patient(s) A 25-year-old cancer survivor with previous Hodgkin disease and relapse. Intervention(s) The ovarian tissue was kept cool for &gt;20 hours in a special transport medium and a special cooling device before it was cryopreserved. After premature ovarian failure due to preconditioning chemotherapy for bone marrow transplantation, the cryopreserved ovarian tissue was transplanted orthotopically. Main Outcome Measure(s) Resumption of ovarian function after transplantation, recovery of fertility, and pregnancy. Result(s) Ovarian function returned in the patient 3 months after transplantation, as shown by follicle development and estrogen production. During the fifth menstrual cycle, mild stimulation with FSH was initiated in accordance with a low-dose protocol. When ultrasonography revealed a follicle 18–20 mm in size in the ovarian graft, hCG was added and the patient had sexual intercourse at the optimal time point. On day 14 of the luteal phase, hCG concentration and vaginal echography confirmed a viable intrauterine pregnancy, which resulted in a healthy live birth. Conclusion(s) Overnight transportation of ovarian tissue appears to be possible in combination with appropriate transportation logistics. However, further investigations are needed before this procedure can be offered as a chance for women to preserve fertility independently of direct access to a tissue-processing bank.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22177311</pmid><doi>10.1016/j.fertnstert.2011.11.047</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 2012-02, Vol.97 (2), p.387-390
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_919226781
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
animal ovaries
Antineoplastic Agents - adverse effects
autografting
Biological and medical sciences
bone marrow transplant
Bone Marrow Transplantation
chemotherapy
cooling
Cryopreservation
Equipment Design
Female
Fertility Agents, Female - administration & dosage
Fertility preservation
Fertility Preservation - methods
follicle-stimulating hormone
freezing
Gynecology. Andrology. Obstetrics
Hodgkin disease
Hodgkin Disease - drug therapy
Hodgkin Disease - surgery
Hodgkin Disease - therapy
human chorionic gonadotropin
Humans
Internal Medicine
Live Birth
Medical sciences
menstrual cycle
Obstetrics and Gynecology
Organ Preservation
Organ Preservation Solutions - therapeutic use
orthotopic
ovarian tissue cryopreservation
ovarian tissue transplantation
Ovary - transplantation
patients
Pregnancy
Primary Ovarian Insufficiency - chemically induced
Primary Ovarian Insufficiency - surgery
Recurrence
relapse
Time Factors
Transplantation Conditioning - adverse effects
Transplantation, Autologous
transportation
Transportation - instrumentation
Treatment Outcome
ultrasonography
women
title Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T13%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Live%20birth%20after%20ovarian%20tissue%20autotransplantation%20following%20overnight%20transportation%20before%20cryopreservation&rft.jtitle=Fertility%20and%20sterility&rft.au=Dittrich,%20Ralf,%20Ph.D&rft.date=2012-02-01&rft.volume=97&rft.issue=2&rft.spage=387&rft.epage=390&rft.pages=387-390&rft.issn=0015-0282&rft.eissn=1556-5653&rft.coden=FESTAS&rft_id=info:doi/10.1016/j.fertnstert.2011.11.047&rft_dat=%3Cproquest_cross%3E919226781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=919226781&rft_id=info:pmid/22177311&rft_els_id=S0015028211028238&rfr_iscdi=true